,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-10-10 01:36:00,"The Dow Jones Industrial Average closed at a record high on Tuesday, bringing up the S&P 500 and Nasdaq, with the financial sector contributing to the market's overall strength ahead of Q3 earnings from the banking sector.",0.8920751214027405,0.044303879141807556,0.06362105160951614,positive,0.8477712273597717
1,2017-10-10 01:36:00,"Shares of component stock Walmart ( WMT ) were also a factor in the Dow's comfortable lead after the retail giant reiterated upbeat 2018 EPS and revenue guidance, as well as announced a plan to buy back $20 billion in stock.",0.9105055928230286,0.02278401516377926,0.06671041995286942,positive,0.887721598148346
2,2017-10-10 01:36:00,"After striking a record high at the open, stocks pulled away from their intraday highs midday in response to Procter & Gamble's ( PG ) decision to keep activist investor Nelson Peltz off the board, and ahead of a pivotal speech by the president of Catalonia who many feared would declare the region's independence from Spain.",0.34321272373199463,0.4735868573188782,0.18320035934448242,negative,-0.13037413358688354
3,2017-10-10 01:36:00,"Peltz vowed to fight on, and Carles Puidgemont deferred a declaration of independence pending international mediation.",0.24686646461486816,0.2585199475288391,0.4946136474609375,neutral,-0.011653482913970947
4,2017-10-10 01:36:00,"Despite an underlying bid for safe havens like gold and U.S. Treasuries, the Dow climbed back towards its record high, assisted by sizable gains from Walmart and Boeing ( BA ), while strength in energy and airline stocks bolstered the S&P 500.",0.9273409247398376,0.04020234942436218,0.03245677053928375,positive,0.8871386051177979
5,2017-10-10 01:36:00,"The Nasdaq struggled under the weight of losses in FANG stocks, but managed a modest gain on strength in biotechs.",0.34228309988975525,0.6093286275863647,0.0483882799744606,negative,-0.2670455276966095
6,2017-10-10 01:36:00,"Here's where the markets stood at the close:

(+) ROKA (+134.57%) A2A Pharmaceuticals may be making an acquisition play

(+) ANAB (+101.17%) Reported positive results from phase 2 clinical trial of ANB020 for atopic dermatitis

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.011666928417980671,0.015262002125382423,0.9730710387229919,neutral,-0.0035950737074017525
7,2017-10-10 01:36:00,Copyright (C) 2016 MTNewswires.com.,0.010173643939197063,0.017617104575037956,0.9722092151641846,neutral,-0.007443460635840893
8,2017-10-10 01:36:00,All rights reserved.,0.01556148286908865,0.01622452400624752,0.9682139754295349,neutral,-0.0006630411371588707
9,2017-10-10 01:36:00,Unauthorized reproduction is strictly prohibited.,0.014759602025151253,0.05492300167679787,0.9303174018859863,neutral,-0.040163397789001465
